In-depth guide

UPDATED JUN 2026

Baby Powder Cancer Lawsuit

Part of the Talcum Powder investigation

The short answer

Johnson & Johnson’s Baby Powder is the product at the center of the talcum powder litigation. Marketed for over a century as safe and gentle, Baby Powder has been linked to ovarian cancer and mesothelioma through both its talc content and asbestos contamination.

J&J discontinued talc-based Baby Powder in North America in 2020 and globally in 2022, but the damage to millions of consumers who trusted the product spans decades.

People's Justice Research TeamUpdated June 11, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Baby Powder: A Century of Trust, Decades of Harm

Johnson & Johnson’s Baby Powder is one of the most recognized consumer brands in history. Introduced in 1886, it became a household staple marketed for infant care, feminine hygiene, and general body care. For generations, mothers dusted their babies with Baby Powder and women used it for daily perineal hygiene, trusting J&J’s assurances of safety and purity. That trust was betrayed by a company that knew for decades that its flagship product was contaminated with asbestos and linked to ovarian cancer.

More than 63,000 lawsuits allege that Baby Powder caused ovarian cancer and mesothelioma. The litigation has produced billions of dollars in verdicts, including the $1.56 billion Craft verdict (2025), the $2.12 billion Ingham verdict (reduced on appeal from $4.69 billion, 2018), and the $117 million Lanzo mesothelioma verdict (2018). These verdicts reflect jurors’ outrage at evidence showing J&J knew its product was dangerous and chose profits over consumer safety.

J&J discontinued talc-based Baby Powder in North America in May 2020 and globally in August 2022, replacing it with a cornstarch-based formula. The company attributed the decision to "declining sales" and "misinformation," but the timing followed years of adverse verdicts, the FDA’s asbestos finding, and the Reuters investigation. The discontinuation was widely interpreted as a tacit acknowledgment that the talc-based product could no longer be defended.

Filing a Baby Powder Cancer Claim

If you or a loved one used Johnson & Johnson Baby Powder and developed cancer, you may be eligible to file a claim. The strongest Baby Powder cancer claims involve women who used the product for perineal hygiene over extended periods and were diagnosed with ovarian cancer, though claims are also viable for mesothelioma, fallopian tube cancer, peritoneal cancer, and endometrial cancer. Men who used Baby Powder and developed mesothelioma may also qualify.

Key steps include documenting your cancer diagnosis and treatment history through medical records, establishing your Baby Powder use through personal testimony, family witness testimony, or purchase records, and consulting an experienced talcum powder attorney who can evaluate the strength of your specific claim. The consultation is free, and attorneys work on contingency — fee terms vary by attorney.

Research & evidence

Scientific Evidence

meta-analysis

IARC Monograph Volume 136: Talc and Acrylonitrile

International Agency for Research on Cancer Working Group. (2024). IARC Monographs on the Identification of Carcinogenic Hazards to Humans

Key findings

  • Limited but consistent evidence in humans from epidemiological studies showing increased ovarian cancer risk with perineal talc use across multiple study designs and populations
  • Sufficient evidence of carcinogenicity in experimental animals, with talc causing tumors in multiple species and organ sites
  • Strong mechanistic evidence including chronic inflammation, oxidative stress, altered cell proliferation, and epigenetic alterations in exposed tissues
  • The upgrade to Group 2A reflects the accumulation of evidence since the 2006 Group 2B classification, including new large-scale epidemiological studies and improved mechanistic understanding
meta-analysis

Prospective Cohort Studies of Talc Use and Ovarian Cancer Risk

Harvard Nurses’ Health Study / Women’s Health Initiative Investigators. (2020). Journal of the National Cancer Institute / Journal of Clinical Oncology

Key findings

  • Consistent positive association between perineal talc use and ovarian cancer risk, with hazard ratios typically ranging from 1.20 to 1.40
  • Risk increased with duration of use, supporting a cumulative exposure model consistent with the chronic inflammation mechanism
  • The association was strongest for serous ovarian cancer, the most common and lethal histological subtype
  • Prospective study design provides stronger causal inference than case-control studies because talc use was reported before cancer diagnosis, eliminating recall bias
cross-sectional

Perineal Talc Use and Ovarian Cancer Risk: A Case-Control Study

Cramer DW, Welch WR, Scully RE, Wojciechowski CA. (1982). The Lancet

Key findings

  • Women who used talcum powder for perineal hygiene had an odds ratio of 1.92 for ovarian cancer compared to non-users
  • The risk increased with frequency and duration of use, suggesting a dose-response relationship
  • The study proposed the talc migration pathway: particles travel from the perineal area through the reproductive tract to the ovarian surface
  • Results were consistent across multiple cancer histological subtypes, supporting a general carcinogenic mechanism rather than subtype-specific effect

FAQ

Frequently Asked Questions

36 QUESTIONS

Yes. More than 63,000 lawsuits have been filed against Johnson & Johnson alleging that Baby Powder and other talc-based products caused ovarian cancer and mesothelioma. You may have a legal claim if you used J&J talcum powder products and were subsequently diagnosed with ovarian cancer, mesothelioma, fallopian tube cancer, peritoneal cancer, or endometrial cancer. The strongest claims involve long-term perineal use with a documented cancer diagnosis. Attorneys handle these cases on contingency. Fee arrangements vary, so confirm terms with any attorney you consult. The MDL 2738 in the District of New Jersey is actively coordinating thousands of federal cases, and state court proceedings continue nationwide.

Dive deeper

Related Guides

7 GUIDES

The full investigation

Part of the Talcum Powder Investigation